Entrada Therapeutics Reports First Quarter 2024 Financial Results

Go back to Entrada Therapeutics Reports First Quarter 2024 Financial Results
(NASDAQ: TRDA) Delayed: 7.17 --0 (-0%)
Previous Close $7.17    52 Week High
Open $7.17    52 Week Low
Day High $7.17    P/E N/A 
Day Low $7.17    EPS
Volume 35